Skip to main content
. 2020 Nov 30;42(2):171–180. doi: 10.1093/asj/sjaa337

Table 3.

Comparison of Characteristics of Women With and Without BII

Characteristic BII No BII P value
Total patients 29 (14.7) 168 (85.3)
Total implants removed 51 (16.8) 252 (83.2)
Age (years) 50.6 [12.3] 52.3 [11.1] 0.475
BMI (kg/m2) 25.4 [4.7] 25.1 [4.7] 0.768
Smoker 7 (24.1) 44 (27.3) 0.721
Allergies 17 (58.6) 64 (38.3) 0.040
Breast cancer therapy
 Radiation therapy 5 (17.2) 41 (25.6) 0.333
 Chemotherapy 6 (27.3) 60 (39.5) 0.069
 Hormone therapy 1 (3.6) 41 (27.0) 0.007
 Immunotherapy 2 (7.1) 9 (5.9) 0.682
Implant reason
 Cosmetic 13 (44.8) 54 (32.1) 0.183
 Reconstruction 16 (55.2) 114 (67.9)
Implant type
 Silicone filled 29 (100.0) 141 (91.6) 0.226
 Saline filled 0 (0.0) 13 (8.3)
Previous implant exchange 10 (34.5) 42 (25.0) 0.537
Implant rupture 11 (40.7) 34 (20.7) 0.023
Time implant in situ (months) 101.0 [58.6] 102.8 [103.8] 0.875
Total exposure to implants (months) 146.5 [109.0] 127.5 [127.0] 0.450
Total exposure to implants (months) 146.5 [109.0] 127.5 [127.0] 0.450

Values are n (%) or mean [standard deviation]. BII, breast implant illness.